Tiny alpaca-derived antibodies point to targets preventing viral infection

June 20, 2016, Whitehead Institute for Biomedical Research

Whitehead Institute scientists have determined how to use alpaca-derived, single-domain antibody fragments (also called VHHs or nanobodies) to perturb cellular processes in mammalian cells, including the infection of human cells by influenza A virus (IAV) and vesicular stomatitis virus (VSV). With improved knowledge of protein activity, scientists can tease apart the roles individual proteins play in cellular pathways, understand how disease corrupts cellular function, and begin to design interventions to rectify such aberrations.

Until now, researchers have relied largely on genetic approaches or small molecules to inhibit protein function. However, these methods' usefulness has limits—genetic alterations may cause unintended phenotypes. Only about 15% of proteins are "druggable" using small molecules.

"Our method is an interesting and, in my opinion, an important addition to the toolbox of the molecular biologist," says Whitehead Member Hidde Ploegh, who is also a Professor of biology at Massachusetts Institute of Technology and an affiliate member of the Koch Institute for Integrative Cancer Research at MIT. "The approach allows you to work in a wild-type protein environment—you don't tinker with the host's protein structure or the genetic makeup of the cell you wish to study, but rather you add a highly specific perturbant."

Ploegh's lab has devised a screening strategy that employs VHHs or nanobodies. These molecules are small, highly specific in what they recognize, and sturdy enough to function in the environment of the cytosol. In earlier work, the Ploegh lab used nanobodies to image the immune system's function in real-time. Working with Whitehead Fellow Sebastian Lourido's lab, VHHs made by the Ploegh lab helped decipher the mode of action of a key enzyme used by the Toxoplasma gondii parasite to invade cells.

In the current line of research, described online in the journal Nature Microbiology, scientists led by postdoctoral researcher Florian Schmidt have developed a rational screening approach that led to the identification of nanobodies that interfere with the ability of IAV and VSV to infect cells.

First, the scientists created nanobodies against IAV or VSV by injecting alpacas with inactivated viruses. Millions of DNA sequences, amplified from the immunized alpacas, were inserted into lentiviruses to enable expression of VHHs in the cytosol of . The transduced human cells were then challenged with IAV or VSV. Any surviving cells must have produced a VHH that interferes with virus replication. Indeed, of the millions of cells transduced, about 260 contained nanobodies that protected the cells against either virus and reduced viral infection by more than 80%. When Schmidt analyzed these hits, he found that the nanobodies jammed the viruses' infection machinery using tactics specific to each virus—anti-IAV VHHs targeted the viral nucleoprotein NP, while the anti-VSVs recognized the viral nucleocaspid N.

Using a similar, nanobody-based method, Schmidt determined the role of the adaptor protein ASC in inflammasome assembly in myeloid cells, but he envisions even broader applications for such screens.

"This technique is a very rapid way of identifying inhibitors of essentially any biological process," he says. "And it allows us to look at all the surfaces of a collection of proteins that we're interested in and find the sites that are important for protein function."

By stabilizing their target molecules, nanobodies act as crystallization chaperones, which allow scientists to more easily solve the proteins' structure. The sites where VHHs bind to proteins are also potential drug targets, as these locations impair the proteins' activity.

Explore further: Tiny antibodies point to vulnerability in disease-causing parasites

More information: Phenotypic lentivirus screens to identify functional single domain antibodies, Nature Microbiology, DOI: 10.1038/nmicrobiol.2016.80

Related Stories

Why humans (and not mice) are susceptible to Zika

May 19, 2016

Flaviviruses—such as Zika, dengue, and yellow fever—have emerged as human (and other primate) pathogens because of their ability to specifically overcome our anti-viral defenses. In the case of Zika, researchers at the ...

Recommended for you

Sightings, satellites help track mysterious ocean giant

August 19, 2018

The sight of a basking shark's brooding silhouette gliding through the waters off western France is more than just a rare treat for sailors—it is a boon for scientists trying to trace its secretive migrations across the ...

Pigs form a visual concept of human faces

August 17, 2018

Contrary to previous studies, pigs appear to have better visual discrimination abilities than had previously been assumed. Cognition researchers from the Messerli Research Institute showed in a new study that pigs not only ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.